With artificial intelligence and personalized medicine playing an increasingly important role in today’s healthcare, one cannot help but wonder about the regulation of these fields. As a Patient Advocate, I am asked to analyze the pros and cons of the ‘checks and...
I wrote my first update (blog at the time) in 2010. It did not happen naturally. Peter wanted a verifiable record of the trips we made and the progress we hoped to achieve. It was meant to be a formal management-outline. I had written hundreds of those management...
Online Patient Advocate Meeting on September 7th 2020 Carin A. Uyl-de Groot studied Health Care Policy and Management at the Erasmus University Rotterdam. From March 1990 onwards she is working at the institute for Medical Technology Assessment/Department of Health...
When initiating the action plan for Latin America, it is of vital importance to identify the challenges that the region faces in terms of oncology. Latin America is made up of 20 countries and has a total of 650 million inhabitants, all have different health policies,...
Sometimes people see Inspire2Live as the driving force behind criticism on the pharmaceutical industry when it comes to the prices of especially newly developed treatments for cancer patients. Although sometimes that happens to be the case, it most certainly...
